Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection

Tyler H.T. Brown, Jason David, Elizabeth Acosta-Ramirez, Jessica M. Moore, Song Lee, Guangming Zhong, Robert E.W. Hancock, Zhou Xing, Scott A. Halperin, Jun Wang

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

An efficacious Chlamydia vaccine is urgently needed to control Chlamydia infections. Heterologous prime-boost vaccination regimens are emerging as a promising strategy for preventing intracellular viral and bacterial infections. However, it remains to be determined if this regimen would be a feasible and effective approach for Chlamydia infection. In this study, we examined the immune response and the protective efficacy induced by various vaccination regimens using a recombinant adenovirus vector expressing the Chlamydia antigen CPAF (AdCPAF) and recombinant CPAF (rCPAF) subunit vaccines formulated with CpG oligodeoxynucleotides and/or a synthetic immunomodulatory peptide HH2 as adjuvants. A single dose of AdCPAF stimulated potent antibody production but weak cellular immune responses in mice. A booster rCPAF vaccine formulated with both CpG and HH2, but not CpG alone or HH2 alone, showed robust adjuvant effects on induction of Th1-biased cellular immune responses in mice primed with AdCPAF. In contrast, a homologous regimen using rCPAF/CpG/HH2 subunit vaccine for both priming and boosting induced a weak antibody response, but potent cellular immunity with a mixed Th1/Th17 profile. Despite the disparities observed in humoral and cellular immune responses, both the heterologous and homologous prime-boost regimens conferred significant immune protection against genital Chlamydia muridarum challenge in C3H/HeN and BALB/c mice.

Original languageEnglish (US)
Pages (from-to)350-360
Number of pages11
JournalVaccine
Volume30
Issue number2
DOIs
StatePublished - Jan 5 2012

Keywords

  • Adenovirus
  • Adjuvant
  • CPAF
  • Chlamydia
  • CpG
  • HH2
  • Heterologous prime-boost
  • Homologous prime-boost
  • Th1
  • Th17
  • Vaccination

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • General Immunology and Microbiology
  • Infectious Diseases
  • Molecular Medicine
  • General Veterinary

Fingerprint

Dive into the research topics of 'Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection'. Together they form a unique fingerprint.

Cite this